Biomarkers and Precision Oncology Forum posted on LinkedIn:
“Uncover Breakthroughs at the Frontlines of Lung Cancer Care.
Asia’s leading experts come together to dissect real-world lung cancer cases in this compelling Molecular Tumor Board session—live and unfiltered.
Dr. Kumar Prabhash leads an incisive discussion with esteemed oncologists from Singapore, India, and Hong Kong—showcasing how biomarker-driven strategies are reshaping treatment choices.
- 31 July 2025 | 16:20 – 16:45 SGT
- Grand Hyatt, Singapore
- CME Applied
More posts featuring Precision Oncology.